Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans
about
Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease.In vitro efficacy of brincidofovir against variola virus.Development of CMX001 for the Treatment of Poxvirus Infections.Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical StudiesOrthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.Highlights in antiviral drug research: antivirals at the horizon.KSHV targeted therapy: an update on inhibitors of viral lytic replication.Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox.The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.Challenges and Achievements in Prevention and Treatment of Smallpox.40 Years without Smallpox.Rabbitpox in New Zealand White Rabbits: A Therapeutic Model for Evaluation of Poxvirus Medical Countermeasures Under the FDA Animal Rule
P2860
Q33900244-65FB9CA0-0297-4D34-8A80-A5A2680072C2Q34057540-1B067A88-1336-4FAA-8BA0-607C32242835Q34801704-5A30C089-0A2F-4BFB-AF29-D3C1D65D0BA2Q35110971-9BBACA84-C047-445C-9815-BC565FFF186EQ37420102-BE272D91-2318-46CD-9067-A1A6FA167785Q37593480-B10F90EA-0148-439A-9975-1BB9C78B9A16Q38007145-7756C856-4BEC-425F-B9A1-35379C650871Q38271135-8CD00A1E-393D-4B05-AF18-15F2B9C842B1Q38957078-1FE67A7E-0392-4589-BA0E-08701970A3D6Q47162853-AE78F775-BA3D-49F9-9140-6719BF6A52EBQ47547852-C34AE53A-CB25-49C1-BE9A-858D4660E0E7Q47552709-104EB868-7242-4563-BCDC-8F74D93BF917Q57817902-D814B0AA-2071-4330-9BF8-119E31FE5A65
P2860
Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@ast
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@en
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@nl
type
label
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@ast
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@en
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@nl
prefLabel
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@ast
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@en
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@nl
P2093
P2860
P921
P356
P1433
P1476
Efficacy of CMX001 as a post e ...... opoxvirus infections of humans
@en
P2093
Alice Robertson
Andrew J Smith
Andrew M Burrage
Bernhard Lampert
Brandi R Manning
Daniele Swetnam
George Painter
Greg Wallace
Mathew M Adams
Randall Lanier
P2860
P356
10.3390/V3010047
P577
2011-01-01T00:00:00Z